KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Palvella Therapeutics (PVLA) Non Operating Income: 2014-2024

Historic Non Operating Income for Palvella Therapeutics (PVLA) over the last 11 years, with Dec 2024 value amounting to $641,000.

  • Palvella Therapeutics' Non Operating Income rose 51.18% to $641,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year increase of 55.76%. This contributed to the annual value of $511,000 for FY2024, which is 28.23% down from last year.
  • According to the latest figures from Q4 2024, Palvella Therapeutics' Non Operating Income is $641,000, which was up 3,305.00% from -$20,000 recorded in Q3 2024.
  • In the past 5 years, Palvella Therapeutics' Non Operating Income ranged from a high of $884,000 in Q1 2021 and a low of -$1.8 million during Q4 2020.
  • For the 3-year period, Palvella Therapeutics' Non Operating Income averaged around $245,455, with its median value being $229,000 (2022).
  • As far as peak fluctuations go, Palvella Therapeutics' Non Operating Income slumped by 2,334.55% in 2020, and later soared by 1,573.33% in 2021.
  • Quarterly analysis of 5 years shows Palvella Therapeutics' Non Operating Income stood at -$1.8 million in 2020, then spiked by 120.62% to $378,000 in 2021, then crashed by 185.98% to -$325,000 in 2022, then soared by 230.46% to $424,000 in 2023, then spiked by 51.18% to $641,000 in 2024.
  • Its last three reported values are $641,000 in Q4 2024, -$20,000 for Q3 2024, and $64,000 during Q2 2024.